Registry for long-term low parathyroid hormone conditions
Part of Hormones & metabolism clinical trials.
This study keeps an ongoing registry (a secured collection of patient information) for people with long-term low parathyroid hormone problems or similar conditions. It may help researchers better understand these conditions and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- Your condition must have been ongoing for more than 12 months.
- You should be under established treatment for your condition.
- You must be able to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information from people with chronic low parathyroid hormone (hypoparathyroidism) or pseudohypoparathyroidism. It aims to better understand these conditions and improve future care. You may join if you are an adult living in Germany.
This study aims to find ways to detect and prevent low parathyroid function after thyroid surgery. If you are having your whole thyroid removed, joining could help researchers learn how to improve recovery.
This trial is creating a registry (a database) for people with parathyroid disease. It will collect information to help doctors better understand and treat these conditions.
This is a registry (data collection) study that gathers information about people diagnosed with chronic hypoparathyroidism in France. It helps researchers better understand how common it is and what it looks like in real life.
This study follows adults with hypoparathyroidism to better understand what symptoms and lab levels change over time. It may help doctors plan future treatments by learning the natural course of the condition, even if you already take standard medicines.
This study looks at how chronic hypoparathyroidism affects daily life and well-being. It may help understand the condition better and improve support for patients.
Hear when a new Comorbidities and Coexisting Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.